12
Total investments
9
Early stage
2
Mid stage
1
Late stage
18y
Years active
Portfolio
12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2019
Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.
The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload.
We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.
Investor
Apr 2019
careviso is a healthcare technology company. By automating the impossible we’re
able to solve the most complex problems in the healthcare industry in real-time: prior authorizations and financial transparency.
careviso created a complete technology platform that increases patient access to care by delivering cost estimates, administrative requirements and approvals in real time.
careviso began with a laboratory focused approach, and our mission is to support patients, providers, and payors with total access to healthcare.
Investor
Mar 2019
Babyscripts is a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. We’ve spent the last nine years delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. For more information on our virtual care solution and to request a demo, visit babyscripts.com.
Investor
Oct 2018
The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being. Currently no marketed therapy exists and aside from the Cyrano product, none are in the pipeline. Cyrano has established the IP estate with the assistance of Wilson Sonsini. Key patents have been issued.
The Cyrano product (CYR-001) repurposes an approved molecule (Theophylline) for this new indication and has been tested with success in a pilot study. Eight out of the 10 patients treated had significant improvement in taste and smell within 2 weeks with no reported side effects. The primary treatment provider will be the Otolaryngologist (Ear, Nose, and Throat specialist) and credible clinical investigators in this specialty have been identified and have expressed interest in participating in the clinical program.
Currently we are seeking a partner to fund up to $5M to fund a Phase 2A study to determine an optimal dose and validate the therapy in a double-blind randomized setting. A Pre-IND meeting with FDA has been held and their positive feedback has been incorporated into the plan. Given the 505(b)(2) regulatory pathway, the company expects the pathway to market to be accelerated.
Member Board of Advisors, Investor
Jan 2018
Graphus® provides a simple, powerful, automated solution that eliminates social engineering and spear phishing attacks against Office 365 and G Suite business Gmail users with no intervention necessary from IT administrators. Graphus® employs graph theory, machine learning, and big data algorithms to establish a TrustGraph® between people, devices, and networks to reveal untrusted communication and detect threats. The Graphus® solution can be activated in minutes for immediate protection.
Investor
2018
Sign In Compliance is The Modern Security Compliance Workspace protecting against serious security risks, containing compliance expenses and the costly administrative burden that distracts teams from their mission. Sign In Compliance is part of the Sign In Solutions suite of brands, backed by growth equity firm, PSG, providing global, cloud-based solutions to manage visitors, employees, workplaces, and beyond.
Investor
May 2017
Atomicorp eliminates the complexity and burden of cybersecurity and compliance by harnessing and extending the power of Open Source Security (OSSEC) and machine learning. Atomicorp aggregates and correlates data across the enterprise to automatically provide high fidelity active response and recovery in cloud and traditional environments. Atomicorp reduces costs, supports mutli-platforms, and provides an interface to manage complex activities across the enterprise for compliance.
Leveraging years of experience in risk management, regulatory affairs, security services, cloud computing, virtualization and shared computer security, Mike and Scott Shinn founded Atomicorp in 2015 in recognition that the cybersecurity market was in need of a low cost, small footprint solution that would not increase the need for more cybersecurity personnel and deliver rapid ROI. Today Atomicorp is meeting those objectives for numerous organizations spanning multiple industries. Building upon the OSSEC platform enables Atomicorp to leverage the technical expertise of the open source community while bringing to market a solution that is easy to use, install and configure and is backed by state-of-the-art commercial support.
Investor
2016
One in four organizations suffered from a cyber attack in the last year, resulting in production, reputation and financial losses. The real problem is adversaries attack companies via third parties, island-hopping their way into target organizations.
At Black Kite, were redefining vendor risk management with the world’s first
global third-party cyber risk monitoring platform, built from a hackers perspective.
With 500+ customers across the globe and counting, were committed to improving the health and safety of the entire planets cyber ecosystem with the industry’s most accurate and comprehensive cyber intelligence. While other security ratings service (SRS) providers try to narrow the scope, Black Kite provides the only standards-based cyber risk assessments that analyze your supply chains cybersecurity posture from three critical dimensions: technical, financial, and compliance.
Investor
2016
Adlumin Inc. provides the enterprise-grade security operations platform and managed detection and response services that keep mid-market organizations secure. With one license and one platform, its patented technology gives organizations and solution providers everything they need for effective threat hunting, incident response, vulnerability management, darknet exposure monitoring, compliance support and much more. The Adlumin platform is feature-rich enough for organizations to operate on their own, yet built specifically to amplify the skills and capabilities of managed service providers.
Investor
2015
Protect Your Endpoints, Identities, Logs, and Employees.
The fully managed security platform that combines endpoint detection and response, Microsoft 365 identity protection, a predictably affordable SIEM and science-based security awareness training. Powered by custom-built enterprise technology for mid-market enterprises, small businesses, and the MSPs that support them and delivered by unrivaled industry analysts in our 24/7 Security Operations Center.
By delivering a suite of purpose-built solutions that meet budget, security, and peace-of-mind requirements, Huntress is how the globe’s most underresourced businesses defend against today’s cyberthreats.
As long as hackers keep hacking, we keep hunting.
Investor
2014
Virgil Security, Inc., makes every software developer into an applied cryptologist. Virgil provides password-free authentication, encryption, distributed immutable data storage via Blockchain, and verification of data, devices, and identities that is quickly and easily integrated into developer products. Virgil provides this via a cloud-based service in combination with open sourced libraries that are available for desktop, embedded (IoT), mobile, and cloud / web applications with support for a wide variety of modern programming languages.
• Finalist for Red Herring's Top 100 North America <http://bit.ly/VS-RNHA>
• One of "region's hottest emerging companies" for Cooley LLP's Capital Call DC <http://bit.ly/VS-Cooley>
• TiE50 Top Start-up Winner at TiEcon 2016 <http://tiecon.org>.
• Top 40 DC-area innovators in the cyber community by Trending40.com.
• Showcased at the 9th Annual Crunchies Awards as "one of the most interesting, creative & successful" 2015 Startup Alley exhibitors by TechCrunch Disrupt.
• Finalist for a Timmy Award as DC’s Best Tech Startup by Tech in Motion <http://bit.ly/VS-TiM>
• One of five "innovative seed & growth-stage cybersecurity companies with outsized potential to transform the trillion dollar mobile space" by CTIA Startup Lab <http://bit.ly/VS-CTIA>
• One of the sixteen hottest up-and-coming early & seed stage technology companies in the Mid-Atlantic by the Mid-Atlantic Venture Association <http://bit.ly/VSBuzz2015>
• One of the Southeast’s thirty-six most innovative startups by 36|86’s Village 36 <http://bit.ly/Village36>
• One of the Top 10 area startups by 36|86’s Southern Series <bit.ly/Virgil-3686>
• One of Cybersecurity Ventures “500 Hot Cybersecurity Companies to Watch in 2015”
• Graduate of the Fall 2014 cohort of the MACH37™ <http://Mach37.com> cyberaccelerator program
#SecureTheFuture #NoMorePasswords #EncryptEverything
#SecuredByVirgil
Founding Board Member
Jul 2008
Invincea is the #1 performing next-gen antivirus security company in the industry. Created by the data scientists at Invincea Labs, X by Invincea stops unknown malware, ransomware, and file-less malware before it can infect an endpoint, without affecting business performance. Based in Fairfax, VA., Invincea proudly protects organizations across the globe and drives the highest level of transparency and accountability in the marketplace. For more information or to take a free Test Drive, visit www.invincea.com.
Experience · 18 entries
All (18)
Investments (12)
Founder (1)
Board (1)
2023
Strategic Advisory Board
May 2023
Blu Venture Investors is a venture capital investment company that supports early stage entrepreneurs in the Mid-Atlantic Region – Maryland, Virginia, Washington, DC and North Carolina. We typically invest $500K to $1.0M in a single round. When larger financing rounds are needed, we actively look to syndicate deals with other investment groups in our network. Our goal is an accelerated, successful exit, for both company founders and investors alike.
Our investors are experienced, successful operating executives with experience in a broad range of industries and business models. Each of our investors has successfully launched new companies, products or services.
The Blu Ventures Affiliate Program is a “by invitation only” group of accredited investors. These investors are provided Blu due diligence materials and quarterly/annual reporting of our portfolio companies. They invest alongside the Blu principals and benefit from our close engagement with our portfolio companies.
Affiliates have the opportunity to invest via an opt-in model which mirrors those deals in which Blu members have already agreed to invest. This unique arrangement affords the affiliate members exposure to deal flow they would not see, substantive due diligence, and institutional-quality documentation and governance—all without the time commitment. Twice per year, we invite the affiliates for a Blu meeting and reception to network with principals and one another.
For more information about Blu Ventures or to submit a business plan, please visit us at http://www.bluventureinvestors.com
2022
Co-Founder & CEO
Jan 2022
Tidal Cyber is redefining how modern security teams think about exposure, detection, and readiness. No longer bound by CVE counts, asset inventories, or checkbox compliance, Tidal Cybers Threat-Led Defense provides a level of specificity not seen before. Organizations can now reduce risk proactively with the precision to answer the most important question in cybersecurity: "Can I defend against the latest threat?"
Through TTPs and procedural-level insights mapped to MITRE ATT&CK, adversary groups and their behavior are embedded into your security strategy, shifting to a proactive, continuous threat-led defense first.
Built by former MITRE ATT&CK® experts and the co-founder of MITREs Center for Threat-Informed Defense, Tidal Cybers threat-led platform introduces a breakthrough level of specificity by mapping techniques and sub-techniques to operationalize adversary procedures. This shift transforms how organizations understand, measure, and act on threat exposure.
Unlike traditional, reactive, or vulnerability-first approaches, Tidal Cyber delivers procedural-level granularity across the MITRE ATT&CK framework, offering unmatched visibility into the "how" of attacker behavior. Their coverage mapping calculates residual risk for each technique and provides stack-specific visibility, highlighting exposures based on how real-world adversaries operate.
2020
Managing Director of Programs
Dec 2020
The MITRE Corporation is working to solve some of the nation’s biggest challenges in defense, cybersecurity, healthcare, homeland security, the judiciary and transportation. MITRE is a not-for-profit corporation committed to the public interest, operating federally funded R&D centers on behalf of U.S. government sponsors. MITRE’s mission-driven teams are dedicated to solving problems for a safer world. To learn more, visit www.mitre.org.
2019
Investor
May 2019
Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.
The pathology industry is beset with increasing caseload and diagnostic complexity, against a globally declining number of pathologists to service the workload.
We believe that digital pathology combined with computer aided diagnostic tools will help make pathologists work more efficiently in the future, and offers a solution to the pending crisis in supply/demand in pathology services.
Investor
Apr 2019
careviso is a healthcare technology company. By automating the impossible we’re
able to solve the most complex problems in the healthcare industry in real-time: prior authorizations and financial transparency.
careviso created a complete technology platform that increases patient access to care by delivering cost estimates, administrative requirements and approvals in real time.
careviso began with a laboratory focused approach, and our mission is to support patients, providers, and payors with total access to healthcare.
Show all 18 entries ↓
Investment activity
2008–2019 · 12 investments
Recent (last 2 years)Earlier
